The Evidence Gap In Hematology: From Trial Endpoints To Patient Outcomes

Hematology trials are becoming increasingly complex as targeted therapies narrow patient populations and intensify competition for eligible participants. In this Parexel-sponsored webinar, our multidisciplinary panel will explore how early RWD/RWE planning, fit-for-purpose evidence, global regulatory strategy, and operational excellence are reshaping hematology development and market access.

Join Parexel experts to learn how sponsors are using real-world insights to improve feasibility, strengthen evidence generation, support regulatory and payer strategies, identify high-performing sites, and accelerate start-up in competitive development landscapes.